Stock and Flow of Peritoneal Dialysis Patients Australia 2001 - 2005 Number of Patients New Patients Transplants Perm. Transfer Deaths No. Dialysing 1796 Patients 2001 2002 2003 2004 2005

Stock and Flow of Peritoneal Dialysis Patients New Zealand 2001 - 2005 Number of Patients New Patients Transplants Perm. Transfer Deaths No. Dialysing 720 Patients 2001 2002 2003 2004 2005

Age of New PD Patients 2005 Australia No. Pats. 9 19 40 84 105 179 203 138 13

Age of Dialysing PD Patients 31-Dec-2005 Australia No. Pats. 18 28 62 177 255 408 487 350 26

PD Patients (%) of all Prevalent Dialysis Australia 31-Dec-2005

Number (Per Million) Prevalent PD Patients Australia 2001 - 2005 % Diab 24% 25% 24% 26% 28%

Number of Prevalent APD/CAPD Patients Australia 2001 - 2005 % APD 28% 35% 40% 43% 43%

Number (Per Million) Prevalent APD Patients Australia 2001 - 2005 % Diab 20% 22% 21% 23% 24%

PD Patients (%) of all Prevalent Dialysis New Zealand 31-Dec-2005

Number (Per Million) Prevalent PD Patients New Zealand 2001 - 2005 % Diab 39% 41% 39% 38% 39%

Number of Prevalent APD/CAPD Patients New Zealand 2000 - 2004 % APD 16% 18% 20% 24% 25%

Number (Per Million) Prevalent APD Patients New Zealand 2001 - 2005 % Diab 29% 35% 33% 39% 38%

Age of New PD Patients 2005 New Zealand No. Pats. 5 3 8 15 43 74 72 23 2

Age of Dialysing PD Patients New Zealand 31-Dec-2005 No. Pats. 9 14 32 57 115 181 203 100 9

Patient Survival - PD at 90 days Censored for Transplant 0.00 0.25 0.50 0.75 1.00 Probability of survival 1 2 3 4 5 Years 1993-1995 (1650) 1996-1998 (1705) 1999-2001 (1844) 2002-2004 (1861) Patient Survival - PD at 90 days Censored for Transplant Australia

Patient Survival - PD at 90 days Censored for Transplant New Zealand 1.00 0.75 Probability of survival 0.50 0.25 1993-1995 (500) 1996-1998 (545) 1999-2001 (664) 2002-2004 (647) 0.00 1 2 3 4 5 Years

Patient Survival - PD at 90 days Censored for Transplant 0.00 0.25 0.50 0.75 1.00 Probability of survival 1 2 3 4 5 Years Non-diabetic (5272) Diabetic (1788) Patient Survival - PD at 90 days Censored for Transplant Australia

Patient Survival - PD at 90 days Censored for Transplant 0.00 0.25 0.50 0.75 1.00 Probability of survival 1 2 3 4 5 Years Non-diabetic (1379) Diabetic (1027) Patient Survival - PD at 90 days Censored for Transplant New Zealand

Patient Survival - PD at 90 days Censored for Transplant 0.00 0.25 0.50 0.75 1.00 Probability of survival 1 2 3 4 5 Years <40 (1062) 40-59 (2110) 60-74 (2970) >=75 (918) Patient Survival - PD at 90 days Censored for Transplant Australia

Patient Survival - PD at 90 days Censored for Transplant 0.00 0.25 0.50 0.75 1.00 Probability of survival 1 2 3 4 5 Years <40 (367) 40-59 (957) 60-74 (909) >=75 (173) Patient Survival - PD at 90 days Censored for Transplant New Zealand

Adjusted Patient Survival - PD at 90 days Censored for Transplant Australia 0.00 0.25 0.50 0.75 1.00 Probability of survival 1 2 3 4 5 Years 1993-1995 (1650) 1996-1998 (1705) 1999-2001 (1844) 2002-2004 (1861)

Adjusted Patient Survival - PD at 90 days Censored for Transplant New Zealand 1.00 0.75 Probability of survival 0.50 0.25 1993-1995 (500) 1996-1998 (545) 1999-2001 (664) 2002-2004 (647) 0.00 1 2 3 4 5 Years

First PD Treatment to First Peritonitis Related to Age at Entry 2001 - 2005 % Survival Australia Age Group

First PD Treatment to First Peritonitis Related to Age at Entry 2001 - 2005 % Survival New Zealand Age Group

First PD Treatment to First Peritonitis Related to Race Australia 1996-2000 Caucasoid 35-54 yrs 55-64 yrs 35-54 yrs Aboriginal/Torres St Maori/Pacific People 55-64 yrs

First PD Treatment to First Peritonitis Related to Race Australia 2001-2005 Caucasoid 55-64 yrs 35-54 yrs 55-64 yrs Aboriginal/Torres St Maori/Pacific People 35-54 yrs

First PD Treatment to First Peritonitis Related to Race New Zealand 1996-2000 Caucasoid 35-54 yrs 55-64 yrs 35-54 yrs 55-64 yrs Maori/Pacific People

First PD Treatment to First Peritonitis Related to Race New Zealand 2001-2005 Caucasoid 35-54 yrs 55-64 yrs 35-54 yrs 55-64 yrs Maori/Pacific People

Number of PD Episodes Number of PD episodes per person Proportion .6 .4 Proportion .2 5 10 Number of PD episodes per person

Vancomycin by Organism Gram positives only Culture negative Coag neg Staph MRSA Staph aureus non MRSA Other Gram Pos .2 .4 .6 .8 Proportion Vancomycin in antibiotic regimen First Second

Initial Antibiotic Regimen .8 .6 Proportion of initial antibiotic regimens .4 .2 NT NSW/ACT Vic Qld SA WA Tas Initial antibiotic regimen Vancomycin Aminoglycoside